Pfizer’s Mylotarg is back ... after the FDA reapproved it in the aggressive blood cancer, acute myeloid leukaemia. The world’s first approved antibody-drug conjugate, where a targeted antibody ...

The company said the discontinuation was due to several reasons,” Reuters news service reported, “including limited interest ...

U.S. Food and Drug Administration. "FDA Approves First COVID ... of Adults and Adolescents with Hemophilia A or B Without Inhibitors." Edgar Online. "Pfizer Inc. Schedule 14A, Proxy Statement ...